Health Economics Research Centre (HERC), University of Oxford

13/03/2026

HERC SHORT COURSES 2026

Registration is now open for bookings for HERC Online short courses for 2026.

This year, we're pleased to offer an exclusive 20% discount when you book multiple online courses.

1. Online: Integrating Economic Evaluation into Clinical Trials, 28 - 29 April 2026
https://www.herc.ox.ac.uk/herc-short-courses/integrating-economic-evaluation-into-clinical-trials

2. Online: Applied Methods of Cost-Effectiveness Analysis, 01 - 05 June 2026
https://www.herc.ox.ac.uk/herc-short-courses/applied-methods-of-cost-effectiveness-analysis

If you would like to make a group booking or have an inquiry, please contact us at herc@ndph.ox.ac.uk for more details.

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functiona...

11/03/2026

NEW PUBLICATION

Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania

Jingjing Jiang, Liz Morrell, Malale Tungu, William F. Mawalla, Clara Chamba, Lulu Chirande, Heronima J. Kashaigili, Elifuraha Mkwizu, Paul S. Ntemi, Godlove Sandi, Kristin Schroeder, Anna Schuh, George M. Ruhago, Sarah Wordsworth & AI-REAL Consortium

BMC Medicine 2026

Diagnosis by liquid biopsy could be cost-effective when used in the community setting to accelerate diagnosis of Burkitt lymphoma in children and young adults in Tanzania, depending on the decision threshold used.

Background Burkitt Lymphoma (BL) is a prevalent and highly aggressive childhood cancer in sub-Saharan Africa (SSA). Outcomes are poor, due in part to delays or inaccuracies in diagnosis. Liquid biopsy (sequencing circulating tumour DNA from blood) is an alternative approach that is non-invasive and....

23/02/2026

NEW PUBLICATION

Towards a Multi-sectoral Approach to Population Health: A Scoping Review of Cross-sectoral Evaluations of Health Interventions

Rositsa Koleva-Kolarova, Emily Hulse, Bertalan Németh, Maureen Rutten-van Mölken, Rhiannon Tudor Edwards, Balázs Babarczy, Balázs Nagy, Sarah Wordsworth, Apostolos Tsiachristas on behalf of the Invest4Health consortium

Applied Health Economics and Health Policy 2026

We looked into economic evaluations that used existing approaches for cross-sectoral evaluation of healthcare interventions to provide an understanding of how these approaches have been applied.

There is a limited number of published cross-sectoral evaluations of health interventions despite the need of public and private investors for global value assessment. Issuing guidance on performing cross-sectoral evaluations and highlighting their need by health technology assessment agencies may improve existing evidence and therefore novel forms of investment in population health interventions.

Background Health interventions, particularly those targeted at health promotion and disease prevention, often have a range of impacts that span beyond the healthcare sector. Making the case for investment in these interventions may require an inventory of costs and outcomes across multiple sectors....

20/02/2026

UPCOMING SEMINAR

Assoc. Prof. Helen Dakin will be leading a workshop at King's Health Economics titled "Interacting Decisions in Economic Evaluation and Health Technology Assessment".

Monday 2 March, 1-2 pm UK BST via MS Teams

Link to join 👇

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functiona...

06/02/2026

NEW PUBLICATION

Cost Effectiveness of Local Anaesthetic Transperineal Versus Transrectal Biopsy: Results from the TRANSLATE Study

TRANSLATE Trial Study Group (Jane Wolstenholme, Filipa Landeiro)

A local anaesthetic ultrasound-guided transperineal prostate biopsy has a higher mean cost and no significant difference in mean quality-adjusted life years, compared with a transrectal ultrasound-guided biopsy at 4 mo after the procedure.

05/02/2026

HERC SHORT COURSES 2026

Registration is now open for bookings for HERC Online short courses for 2026.
This year, we're pleased to offer an exclusive 20% discount when you book multiple online courses.

1. Online: Introduction to Health Economic Evaluation, 03 - 04 March 2026 or 22 - 23 September 2026
https://www.herc.ox.ac.uk/herc-short-courses/introduction-to-health-economic-evaluation

2. Online: Integrating Economic Evaluation into Clinical Trials, 28 - 29 April 2026
https://www.herc.ox.ac.uk/herc-short-courses/integrating-economic-evaluation-into-clinical-trials

3. Online: Applied Methods of Cost-Effectiveness Analysis, 01 - 05 June 2026
https://www.herc.ox.ac.uk/herc-short-courses/applied-methods-of-cost-effectiveness-analysis

If you would like to make a group booking or have an inquiry, please contact us at herc@ndph.ox.ac.uk for more details.

If you are certain you have the correct web address but are encountering an error, please contact the Site Administration. Thank you.

26/01/2026

NEW PUBLICATION

Correspondence on “Parents’ perceptions of the utility of genetic testing in the NICU” by Callahan et al

Sally L. Sansom, Chloe Mighton, Hadley Stevens Smith

Value in Health 2026

15/01/2026

HERC NEWS

HERC at

HERC researchers are attending the winter hosted by the Centre for Health Economics 👇

- Helen Dakin, The Trial Economics Planner (TEP): A tool to support decisions about incorporating economic components in clinical trials

- Xinyu Li, Integrating Secular Trends into Health Economic Models

- James Lathe, On measuring labour tax revenue and welfare benefits in health economic evaluations: relevance and practical integration

- Fred McElwee, A cost is a cost is a cost - Or is it? The Implications of Industry-Wide Rebate Mechanisms for Economic Evaluation and Health Technology Assessment

https://hesg.org.uk/meetings/winter-2026-university-of-york/

Winter 2026: University of YorkThe Health Economists’ Study Group Winter 2026 Meeting will be hosted by the Centre for Health Economics, University of York, from 14th-16th January 2026.Registration is now closed. Meeting scheduleThe HESG Winter Meeting will take place at The Milner York hotel, Yor...

13/01/2026

HERC NEWS



Kristian Mallon presented two posters:

- Q-squared as a mapping model performance metric in gastrointestinal disease

Incorporating Q-squared into future mapping studies could improve assessment of model performance given its ability to directly assess predictive accuracy, in a way that can be directly compared between samples and instruments.

https://www.sciencedirect.com/science/article/pii/S1098301525060814

- The HERC Database of Mapping Studies

As of 2025, the HERC Database includes over 279 mapping studies across a wide range of clinical areas, including cancer, infectious diseases, cardiovascular disease, digestive system diseases, central nervous system disorders, and musculoskeletal disorders. It includes studies mapping from 113 different source instruments. Ordinary least squares (OLS) regression remains the most frequently applied model (81%).

https://www.sciencedirect.com/science/article/pii/S1098301525061005

The studies were led by Helen Dakin and co-authored by Richéal Burns, Lucy Abel, Rositsa Koleva-Kolarova, and Yaling Yang.

12/01/2026

HERC NEWS



Junwen Zhou presented "Modeling Framework for Assessing Cost-Effectiveness of New Treatments in Chronic Kidney Disease".

This new Chronic Kidney Disease (CKD) model, that was further integrated with evidence of quality of life and healthcare costs, can inform assessments of cost-effectiveness of treatments modifying CKD progression and cardiovascular risks in CKD.

The study was co-authored by Claire Williams and Borislava Mihaylova.

07/01/2026

HERC NEWS

HERC at 2025

Liz Morrell presented "Tell me a story: a randomised study comparing table and narrative presentations of a choice experiment" in a podium session on preference elicitation methods. Reassuringly, the study found little difference between presentation formats.

The study was co-authored by James Buchanan, Laurence (Larry) Roope, Koen Pouwels, Julie Robotham, Sarah Walker and Sarah Wordsworth.

Link to published abstract 👇

15/12/2025

NEW PUBLICATION

Supporting women with adherence to adjuvant endocrine therapy (SWEET): feasibility study of the HT&Me intervention

SWEET Research Team (includes Jane Wolstenholme and Helen Dakin)

https://www.sciencedirect.com/science/article/pii/S1462388925002509?via%3Dihub

SWEET trial protocol paper
https://link.springer.com/article/10.1186/s13063-025-09056-6